Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2021-02-08 5:24 pm Unchanged | 13G | SURFACE ONCOLOGY INC SURF | Novartis Institutes for BioMedical Research Inc. | 3,948,482 9.71% | 0 (Unchanged) | View |
| 2021-02-02 1:03 pm Sale | 13G | SURFACE ONCOLOGY INC SURF | Atlas Venture Fund IX L.P. | 2,945,453 7.24% | -1,709,000 (-36.72%) | View |
| 2020-12-10 09:15 am Purchase | 13G | SURFACE ONCOLOGY INC SURF | FMR LLC | 2,048,321 5.035% | 750,038 (+57.77%) | View |
| 2020-05-29 5:06 pm Purchase | 13G | SURFACE ONCOLOGY INC SURF | BIOTECHNOLOGY VALUE FUND L P | 2,125,650 5.8% | 2,125,650 (New Position) | View |
| 2020-05-29 4:13 pm Purchase | 13G | SURFACE ONCOLOGY INC SURF | EcoR1 Capital LLC | 5,033,861 12.8% | 3,732,148 (+286.71%) | View |
| 2020-05-29 4:05 pm Purchase | 13G | SURFACE ONCOLOGY INC SURF | Venrock Healthcare Capital Partners II L.P. | 3,877,895 9.9% | 3,877,895 (New Position) | View |
| 2020-02-14 2:40 pm Sale | 13G | SURFACE ONCOLOGY INC SURF | EcoR1 Capital LLC | 1,301,713 4.7% | -959,615 (-42.44%) | View |
| 2020-02-13 4:17 pm Purchase | 13G | SURFACE ONCOLOGY INC SURF | Lilly Ventures Fund I LLC | 3,484,618 12.5% | 30,741 (+0.89%) | View |
| 2020-02-13 10:51 am Unchanged | 13G | SURFACE ONCOLOGY INC SURF | New Enterprise Associates 14 L.P. | 3,312,877 11.9% | 0 (Unchanged) | View |
| 2020-02-07 11:30 am Sale | 13G | SURFACE ONCOLOGY INC SURF | FMR LLC | 1,298,283 4.656% | -394,378 (-23.30%) | View |
| 2020-02-04 2:58 pm Unchanged | 13G | SURFACE ONCOLOGY INC SURF | Atlas Venture Fund IX L.P. | 4,654,453 16.69% | 0 (Unchanged) | View |